指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

通过机器学习和共识聚类识别儿童脓毒症中的糖酵解相关特征与分子亚型:诊断与治疗意义

Identification of Glycolysis-Related Signature and Molecular Subtypes in Child Sepsis Through Machine Learning and Consensus Clustering: Implications for Diagnosis and Therapeutics.
指南 / 共识 · Mol Biotechnol · 2025-02-20
一句话结论儿童脓毒症中糖酵解通路活性升高,GNPDA2、PRKACB、TGFBI为潜在诊断标志物,并区分出C2亚型(糖酵解、糖代谢和炎症更高)。

该研究应用GSVA算法对GSE26440数据集进行糖酵解通路评分,并通过LASSO和逻辑回归识别关键糖酵解相关基因(GRGs)。利用这些GRGs构建预测列线图,并在原始数据集(GSE26440)及独立验证数据集(GSE13904和GSE26378)中显示显著诊断准确性。通过共识聚类区分出两种脓毒症亚型,C2亚型表现出更高的GRGs、糖代谢和炎症,且免疫浸润和检查点基因表达在亚型间存在差异。标志基因经动物实验验证。研究提示糖酵解相关标志物和分子亚型可能有助于改进儿童脓毒症的诊断和治疗策略(包括免疫治疗)。

要点

  • 儿童脓毒症患者糖酵解通路活性升高。
  • GNPDA2、PRKACB、TGFBI被识别为基于糖酵解的潜在诊断标志物。
  • 基于GRGs的列线图在原始数据集GSE26440和验证数据集GSE13904、GSE26378中显示显著诊断准确性。
  • 共识聚类区分出两种脓毒症亚型,C2亚型具有更高的GRGs、糖代谢和炎症。
  • 免疫浸润和检查点基因表达在两种亚型间存在差异。

适用人群与场景

  • 儿童脓毒症患者(研究基于公共数据集GSE26440、GSE13904和GSE26378)。

研究设计与关键结果

  • 研究类型:基于机器学习和共识聚类的生物信息学分析,辅以动物实验验证。
  • 数据集:GSE26440(原始),GSE13904和GSE26378(验证)。
  • 糖酵解通路活性在脓毒症患者中升高。
  • 通过LASSO和逻辑回归,GNPDA2、PRKACB和TGFBI被识别为潜在的基于糖酵解的诊断标志物。
  • 列线图在原始数据集(GSE26440)和独立验证数据集(GSE13904和GSE26378)中均显示出显著的诊断准确性。
  • 共识聚类区分出两种脓毒症亚型,C2亚型表现出更高的GRGs、糖代谢和炎症。
  • 免疫浸润和检查点基因表达在亚型间存在差异。
  • 标志基因经动物实验验证。

证据类型、等级与局限

  • 证据类型:基于公共基因表达数据集的分析研究,结合动物实验验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐;研究结论认为糖酵解相关诊断标志物和分子亚型可能增进对脓毒症的理解,并可能带来更好的诊断和治疗策略(包括免疫治疗)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Pediatric sepsis remains one of the leading causes of mortality in children worldwide. Despite advances in medical care, the prognosis of pediatric sepsis is still poor, necessitating the need for more precise diagnostic and therapeutic strategies. Recently, metabolic reprogramming, particularly glycolysis, has been implicated in the pathogenesis of sepsis, offering new avenues for biomarker discovery and targeted therapy. We applied the GSVA algorithm to the GSE26440 dataset to score glycolysis pathways and identified key glycolysis-related genes (GRGs) using LASSO and logistic regression. We then constructed a predictive nomogram with these GRGs and used consensus clustering to define new molecular subgroups, followed by analyzing their metabolic and immune characteristics. The signature genes were validated by animal experiments. We found increased glycolysis pathway activity in sepsis patients. Through the application of LASSO and logistic regression, GNPDA2, PRKACB, and TGFBI emerged as potential glycolysis-based diagnostic markers. The nomogram showed significant diagnostic accuracy in both the original (GSE26440) and the separate validation datasets (GSE13904 and GSE26378). We distinguished two sepsis subtypes, with the C2 subtype exhibiting higher GRGs, glucose metabolism, and inflammation. Immune infiltration and checkpoint gene expression also varied between the subtypes. Our research identifies glycolysis-based diagnostic markers and molecular subtypes in sepsis, enhancing our understanding and potentially leading to better diagnosis and treatment strategies, including immunotherapy.

来源:Mol Biotechnol,查看原文。版权归原作者所有。

参考来源

  1. Ma C, Wang J. Identification of Glycolysis-Related Signature and Molecular Subtypes in Child Sepsis Through Machine Learning and Consensus Clustering: Implications for Diagnosis and Therapeutics. Mol Biotechnol. 2025. PMID: 39976858. doi:10.1007/s12033-025-01379-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。